Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision was updated to v3.6.6, reflecting a CMS/software maintenance update rather than a change to study data or visible content.SummaryDifference0.0%

- Check20 days agoChange DetectedA new entry '2017 ( U.S. NIH Grant/Contract )' was added to the Study ID Numbers, recording an additional funding attribution for the trial.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision label v3.6.5 was added, replacing the previous v3.6.4.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's underlying version rather than changes to study details.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, indicating an updated platform build behind the page.SummaryDifference0.0%

- Check91 days agoChange DetectedRecruitment status is updated to show no participant enrollment, and new help sections plus a revised Intervention/Treatment heading with an updated revision tag (v3.6.0) were added.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.